Join Our Free Webinar and Q&A Session
In biopharmaceutical formulation development, waiting on long-term stability data can slow progress and introduce uncertainty. This session explores how kinetic aggregation evaluation helps you identify risks earlier and make more confident decisions—faster.
In just 30 minutes, you’ll learn how to integrate high-throughput aggregation kinetics into your formulation workflow to improve clarity and accelerate development timelines.
What you will learn:
If you can’t attend live, register anyway, and we’ll send you the recording!
Speakers
Host
Troy Sullivan
Yokogawa Business Development
Mr. Sullivan is a Business Development Consultant with Yokogawa, supporting the Fluence Analytics portfolio. He focuses on helping biopharmaceutical organizations improve process insight and decision-making through advanced analytics and high-throughput measurement technologies.
Presenter
Thorben Hoeltkemeier, PhD
Novartis
Dr. Thorben Höltkemeier is an Expert in Science and Technology at Novartis, based in Basel, Switzerland, where he works within drug product development and biopharmaceutical research. His work focuses on protein aggregation, formulation stability, and the application of high‑throughput and analytical methods to improve biopharmaceutical development. He has contributed to research advancing particle analysis techniques and aggregation kinetics, supporting more robust and predictive formulation strategies.
Presenter
Cédric Thauvin, PhD
Novartis
Dr. Cédric Thauvin is a scientist at Novartis based in Basel, Switzerland, with a background in pharmaceutical sciences, organic chemistry, and polymer chemistry. His work focuses on drug product development and formulation science, including the design of advanced materials and approaches to improve the stability and performance of biopharmaceuticals. He has contributed to research in nanoparticle-based drug delivery systems and polymer-based formulation strategies.
Register Now